Streetbeat News

Analyst Ratings

GMED

Truist Securities analyst Richard Newitter has reiterated a 'Hold' rating on Globus Medical (NYSE:GMED) and maintained a price target of $65.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2023 | 2:21 pm

AMGN

Truist Securities analyst Robyn Karnauskas has reiterated a 'Hold' rating on Amgen (NASDAQ:AMGN) and maintained a price target of $260.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2023 | 2:21 pm

GPK

Truist Securities analyst Michael Roxland has reiterated a 'Buy' rating on Graphic Packaging Holding (NYSE:GPK) and maintained a price target of $31.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2023 | 2:18 pm

ADBE

A significant bullish stance on Adobe (NASDAQ:ADBE) has been observed through unusual options activity. The sentiment among these big-money traders is 70% bullish and 30% bearish. The whales have been targeting a price range from $450.0 to $600.0 for Adobe over the last 3 months. B of A Securities upgraded its action to Buy with a price target of $630. Adobe's next earnings are expected to be released in 9 days.

Portfolio Pulse from Benzinga Insights

September 05, 2023 | 2:16 pm

AVY

Truist Securities analyst Michael Roxland has reiterated a 'Buy' rating on Avery Dennison (NYSE:AVY) and maintained a price target of $215.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2023 | 2:16 pm

MELI

A significant bullish stance has been taken on MercadoLibre (NASDAQ:MELI) by a large investor, as indicated by unusual options activity. The sentiment among these big-money traders is split between 58% bullish and 41% bearish. The whales have been targeting a price range from $1040.0 to $1800.0 for MercadoLibre over the last 3 months. Several financial institutions have maintained their positive ratings on MercadoLibre, with price targets ranging from $1500 to $2180.

Portfolio Pulse from Benzinga Insights

September 05, 2023 | 2:16 pm

ADVM

Truist Securities analyst Joon Lee has reiterated a 'Buy' rating on Adverum Biotechnologies (NASDAQ:ADVM) and maintained a $6 price target.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2023 | 2:03 pm

SHOP

A significant amount of unusual options activity has been observed for Shopify (NYSE:SHOP), with a majority of investors taking a bearish stance. Of the 12 strange trades detected, 75% were bearish and 25% bullish. The total amount for the 8 puts was $392,313 and for the 4 calls was $238,815. Whales have been targeting a price range from $60.0 to $240.0 for Shopify over the last 3 months. The price of SHOP is currently down -0.9% at $66.11. Analysts have mixed opinions, with some upgrading their action to Buy and others downgrading to Outperform or maintaining a Hold rating.

Portfolio Pulse from Benzinga Insights

September 05, 2023 | 2:02 pm

JPM

A whale investor has taken a bearish stance on JPMorgan Chase (NYSE:JPM), with 56% of the investors opening trades with bearish expectations. The whale has been targeting a price range from $85.0 to $190.0 for JPMorgan Chase over the last 3 months. The current price of JPM is $146.69, down -0.09%. Oppenheimer has maintained their Outperform rating on JPMorgan Chase, with a price target of $219.

Portfolio Pulse from Benzinga Insights

September 05, 2023 | 2:02 pm

MRK

Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Merck & Co (NYSE:MRK) and maintained a price target of $135.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2023 | 2:01 pm